# A Clinical Trial to Evaluate the Corneal Endothelial Health of DED Subjects Treated With Cyclosporine

> **NCT06329661** · PHASE4 · COMPLETED · sponsor: **Novaliq GmbH** · enrollment: 204 (actual)

## Conditions studied

- Dry Eye Disease

## Interventions

- **DRUG:** Cyclosporine ophthalmic solution, 0.1%
- **DRUG:** Saline solution, 0.6%

## Key facts

- **NCT ID:** NCT06329661
- **Lead sponsor:** Novaliq GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-22
- **Primary completion:** 2025-07-30
- **Final completion:** 2025-07-30
- **Target enrollment:** 204 (ACTUAL)
- **Last updated:** 2025-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06329661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06329661, "A Clinical Trial to Evaluate the Corneal Endothelial Health of DED Subjects Treated With Cyclosporine". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06329661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*